[Gelvisol as a symptomatic agent for treating generalized forms of malignant tumors].
In the paper, the results of clinical applications of a complex peroral therapeutic solution--gelvisol for symptomatic treatment of generalized malignant tumors of the breast, lung and thyroid are summarized. The solution was administered in a dose of 50-60 ml 5-6 times a day during 12-14 days. A positive effect was manifested in the improved general condition of patients, better appetite, less intoxication of the organisms, better functioning of the liver and kidneys.
D000284:Administration, Oral; D001943:Breast Neoplasms / Q000188:drug therapy*; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005971:Glutamates / Q000008:administration & dosage / Q000627:therapeutic use*; D006601:Hexoses / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*; D013964:Thyroid Neoplasms / Q000188:drug therapy*; D013997:Time Factors; D014815:Vitamins / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; D005971:Glutamates; D006601:Hexoses; D014815:Vitamins; C016470:ascorbic acid, B2, B6, bendazol, caffeine, citric acid, distilled H2O, ethanol, gelatin, glutamic acid, KCl, MgCl2, NaCl, sorbitol, sucrose, vitamins B1 drug combination
Gel'visol kak simptomaticheskoe sredstvo dlia lecheniia bol'nykh generalizovannymi formami zlokachestvennykh opukholeĭ.